MENDLEIN JOHN

Director at Monogram Biosciences, Inc. · on record since Apr 11, 2006
Director at FATE THERAPEUTICS INC · on record since Sep 30, 2013
Director at LIFELINE SYSTEMS CO · on record since May 14, 2015
CEO and Director at LIFELINE SYSTEMS CO · on record since Jan 29, 2016
Director at Editas Medicine, Inc. · on record since Feb 4, 2016
Director at ACLARA BIOSCIENCES INC · on record since Dec 10, 2004
See Remarks at AGRICULTURAL EQUIPMENT CORP · on record since Dec 7, 2018
Director at Omega Therapeutics, Inc. · on record since Jul 29, 2021

Insider trading activity of MENDLEIN JOHN

Transactions on record: 62; since Dec 10, 2004

Open-market buys: 12; $1.2M

Open-market sells: 3; $1.1M

Companies traded: 6; last filing May 30, 2025

Figures computed from official regulatory filings — .

Companies where MENDLEIN JOHN has traded

FATE THERAPEUTICS INC24 tx · $2M · May 30, 2025
Omega Therapeutics, Inc.3 tx · Jun 21, 2024
LIFELINE SYSTEMS CO22 tx · $379.9K · May 10, 2019
Editas Medicine, Inc.2 tx · Jun 19, 2017
Monogram Biosciences, Inc.6 tx · Jan 21, 2009
ACLARA BIOSCIENCES INC5 tx · $311.4K · Dec 10, 2004

Track record of MENDLEIN JOHN

Statistical track record

Free

Open-market buys: 13

Last buy: Jan 13, 2023

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of MENDLEIN JOHN

Co-insiders of MENDLEIN JOHN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 21, 2024	AwardD (derivative)	25,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2024	AwardD (derivative)	40,000	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	18,118	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 7, 2023	AwardD (derivative)	40,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jan 20, 2023	ExerciseD (derivative)	28,461	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jan 20, 2023	Exercise	28,461	1.37 USD	$39K	SEC
FATE THERAPEUTICS INCListing on record	Jan 13, 2023	Buy	88,048	5.67 USD	$499.2K	SEC
FATE THERAPEUTICS INCListing on record	Jan 13, 2023	Buy	36,631	5.43 USD	$198.9K	SEC
FATE THERAPEUTICS INCListing on record	Jun 13, 2022	Award	8,650	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 13, 2022	AwardD (derivative)	11,893	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	18,118	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 6, 2022	Sell	-1,364	22.79 USD	$31.1K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Exercise	31,562	1.63 USD	$51.4K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Sell	-12,069	35.48 USD	$428.2K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Sell	-19,493	34.73 USD	$677K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	ExerciseD (derivative)	-31,562	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 4, 2021	Award	2,681	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 4, 2021	AwardD (derivative)	4,334	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	May 5, 2020	AwardD (derivative)	16,000	—	—	SEC
LIFELINE SYSTEMS COListing unverified	May 10, 2019	AwardD (derivative)	20,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	May 7, 2019	AwardD (derivative)	16,000	—	—	SEC
LIFELINE SYSTEMS COListing unverified	Dec 26, 2018	Buy	195,000	0.42 USD	$81.9K	SEC
LIFELINE SYSTEMS COListing unverified	Dec 26, 2018	Buy	50,000	0.41 USD	$20.5K	SEC
LIFELINE SYSTEMS COListing unverified	May 17, 2018	AwardD (derivative)	20,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 21, 2024	AwardD (derivative)	25,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 11, 2024	AwardD (derivative)	40,000	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 9, 2023	AwardD (derivative)	18,118	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 7, 2023	AwardD (derivative)	40,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jan 20, 2023	ExerciseD (derivative)	28,461	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jan 20, 2023	Exercise	28,461	1.37 USD	$39K	SEC
FATE THERAPEUTICS INCListing on record	Jan 13, 2023	Buy	88,048	5.67 USD	$499.2K	SEC
FATE THERAPEUTICS INCListing on record	Jan 13, 2023	Buy	36,631	5.43 USD	$198.9K	SEC
FATE THERAPEUTICS INCListing on record	Jun 13, 2022	Award	8,650	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 13, 2022	AwardD (derivative)	11,893	0.00 USD	—	SEC
Omega Therapeutics, Inc.Listing unverified	Jun 10, 2022	AwardD (derivative)	18,118	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 6, 2022	Sell	-1,364	22.79 USD	$31.1K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Exercise	31,562	1.63 USD	$51.4K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Sell	-12,069	35.48 USD	$428.2K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	Sell	-19,493	34.73 USD	$677K	SEC
FATE THERAPEUTICS INCListing on record	Mar 11, 2022	ExerciseD (derivative)	-31,562	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 4, 2021	Award	2,681	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	Jun 4, 2021	AwardD (derivative)	4,334	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	May 5, 2020	AwardD (derivative)	16,000	—	—	SEC
LIFELINE SYSTEMS COListing unverified	May 10, 2019	AwardD (derivative)	20,000	0.00 USD	—	SEC
FATE THERAPEUTICS INCListing on record	May 7, 2019	AwardD (derivative)	16,000	—	—	SEC
LIFELINE SYSTEMS COListing unverified	Dec 26, 2018	Buy	195,000	0.42 USD	$81.9K	SEC
LIFELINE SYSTEMS COListing unverified	Dec 26, 2018	Buy	50,000	0.41 USD	$20.5K	SEC
LIFELINE SYSTEMS COListing unverified	May 17, 2018	AwardD (derivative)	20,000	0.00 USD	—	SEC